2005 Trends in Life Sciences Partnering and Collaborations

Ten years ago, when a biotech company needed to raise capital, the avenue most frequently sought was the capital markets. Today, rising drug development costs can approach $1 billion, making a biotech's need for capital more intense than ever.


Don’t have an account yet?